XML 28 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Shareholders' Equity (Tables)
9 Months Ended
Sep. 30, 2012
Shareholders' Equity  
Share-Based Activity
  Three Months Ended Nine Months Ended
  September 30, September 30,
  2012 2011 2012 2011
             
Share-based compensation expense $ 1,707 $ 1,591 $ 5,119 $ 4,762
Fair value of shares vested    -   227   6,425   2,589
Cash received from option exercises    5,256   132   11,928   4,760
Tax benefit from option exercises    739   26   1,268   489
Schedule Of Changes In Non-Vested Restricted Shares
      Weighted
    Number Average
    of Grant
    Shares Price
        
Non-vested shares at December 31, 2011  732,412 $ 21.91
 Shares granted   281,429   26.78
 Shares vested  (183,019)   25.98
 Shares forfeited   (2,136)   26.26
       
Non-vested shares at September 30, 2012  828,686 $ 22.50
Schedule Of Stock Option Activity
         Weighted
         Average
      Weighted Remaining
    Number Average Contractual
    of Exercise Term
    Shares Price (in years)
          
Outstanding at December 31, 2011  2,510,054 $ 23.09  3.4
 Options exercised with total intrinsic value of $11,928,000  (579,598)   20.58  
 Options terminated   (5,625)   21.85  
          
Outstanding at September 30, 2012 with aggregate intrinsic value of $8,728,000  1,924,831 $ 23.85  2.9
          
Vested at September 30, 2012 with aggregate intrinsic value of $8,728,000  1,924,831 $ 23.85  2.9
          
Exercisable at September 30, 2012 with aggregate intrinsic value of $8,728,000  1,924,831 $ 23.85  2.9
Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share
     Three Months Ended September 30, Nine Months Ended September 30,
          Per      Per
     Earnings Shares  Share Earnings Shares  Share
     (Numerator) (Denominator) Amount (Numerator) (Denominator) Amount
                    
2012:                
Net earnings from continuing operations attributable to                 
 AmSurg Corp. per common share (basic) $ 15,437  30,819 $ 0.50 $ 47,352  30,727 $ 1.54
                    
Effect of dilutive securities options and                 
 non-vested shares    -  878      -  831   
                    
Net earnings from continuing operations attributable to                 
 AmSurg Corp. per common share (diluted)  $ 15,437  31,697 $ 0.49 $ 47,352  31,558 $ 1.50
                    
Net earnings attributable to AmSurg Corp.                 
 per common share (basic)  $ 15,437  30,819 $ 0.50 $ 45,749  30,727 $ 1.49
                  
Effect of dilutive securities options and                 
 non-vested shares    -  878      -  831   
                    
Net earnings attributable to AmSurg Corp.                 
 per common share (diluted) $ 15,437  31,697 $ 0.49 $ 45,749  31,558 $ 1.45
                    
2011:                
Net earnings from continuing operations attributable to                 
 AmSurg Corp. per common share (basic) $ 13,017  30,436 $ 0.43 $ 37,305  30,424 $ 1.23
                    
Effect of dilutive securities options and                 
 non-vested shares    -  726      -  750   
                    
Net earnings from continuing operations attributable to                 
 AmSurg Corp. per common share (diluted)  $ 13,017  31,162 $ 0.42 $ 37,305  31,174 $ 1.20
                    
Net earnings attributable to AmSurg Corp.                 
 per common share (basic)  $ 13,126  30,436 $ 0.43 $ 36,449  30,424 $ 1.20
                  
Effect of dilutive securities options and                 
 non-vested shares    -  726      -  750   
                    
Net earnings attributable to AmSurg Corp.                 
 per common share (diluted) $ 13,126  31,162 $ 0.42 $ 36,449  31,174 $ 1.17